🔗 Permalink

Inventor profile of:

Jean-Simon Diallo

City:

Ottawa

Country:

Canada

Published Applications:

Last publication date:

2026-01-15

Top Assignees for applications by Jean-Simon Diallo

The entities that hold a legal rights for patent applications filed by inventor Diallo Jean-Simon:

OTTAWA HOSPITAL RESEARCH INSTITUTE 7 Ottawa, Canada
OTTAWA HOSPITAL RESEARCH INSTITUTE 4 Ottawa, ON Canada
TURNSTONE LIMITED PARTNERSHIP 3 TORONTO, Canada
UNIVERSITY OF OTTAWA 2 Ottawa, Canada
Ottawa Hospital Research Institute and University of Ottawa 2 Ottawa, Canada
UNIVERSITY OF OTTAWA 1 Ottawa, ON Canada
Ottawa Hospital Research Institute 1 Ontario, Canada
Ottawa Health Research Institute 1 Ottawa, Ontario, Canada
Colorado State University Research Foundation 1 Fort Collins, CO United States

Recent patent applications by Diallo Jean-Simon

Jean-Simon Diallo from Ottawa, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15

US20260015592A1

Chemistry; metallurgy

NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF

#2 | 2024-10-31

US20240360115A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION

#3 | 2024-09-19

US20240307469A1

Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING PRODUCTION, GROWTH, SPREAD, OR ONCOLYTIC AND IMMUNOTHERAPEUTIC EFFICACY OF INTERFERON-SENSITIVE VIRUSES

#4 | 2024-09-05

US20240293352A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING VANADIUM SALTS

#5 | 2022-07-14

US20220220101A1

Chemistry; metallurgy

Compositions and methods for viral sensitization

#6 | 2020-11-12

US20200354351A1

Chemistry; metallurgy

Compositions and methods for viral sensitization

#7 | 2020-09-03

US20200276253A1

Human necessities

Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses

#8 | 2019-08-01

US20190231832A1

Human necessities

Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses

#9 | 2018-08-23

US20180237753A1

Chemistry; metallurgy

Compositions and methods for enhancing virus replication

#10 | 2018-03-08

US20180064805A1

Human necessities

Method of Vaccination Comprising a Histone Deacetylase Inhibitor

#11 | 2016-05-12

US20160130563A1

Chemistry; metallurgy

Compositions and methods for enhancing virus replication

#12 | 2015-07-23

US20150202240A1

Human necessities

Compositions and methods for enhancing virus efficacy

#13 | 2014-07-10

US20140193458A1

Human necessities

Method of vaccination comprising a histone deacetylase inhibitor

#14 | 2012-05-31

US20120134963A1

Human necessities

Compositions and methods for enhancing virus efficacy

#15 | 2011-02-24

US20110044952A1

Human necessities

AMPLIFICATION OF CANCER-SPECIFIC ONCOLYTIC VIRAL INFECTION BY HISTONE DEACETYLASE INHIBITORS

InventorID:

831891 ⎘